Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Advocate Healthcare/Good Shepard Hospital
mi
from
Barrington, IL
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Advocate Healthcare/Good Shepard Hospital
mi
from
Barrington, IL
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
John Stroger Hospital of Cook County
mi
from
Chicago, IL
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
John Stroger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Peoria Surgical Group
mi
from
Peoria, IL
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Peoria Surgical Group
mi
from
Peoria, IL
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Colon and Rectal Surgery-NEICRS Group
mi
from
Fort Wayne, IN
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Colon and Rectal Surgery-NEICRS Group
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Kenderick Regional Center
mi
from
Indianapolis, IN
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Kenderick Regional Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Spectrum Health -Ferguson Group
mi
from
Grand Rapids, MI
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Spectrum Health -Ferguson Group
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Duluth Clinic
mi
from
Duluth, MN
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Duluth Clinic
mi
from
Duluth, MN
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Albany Medical College
mi
from
Albany, NY
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
New York-Presbyterian Hospital
mi
from
New York, NY
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
University Hospitals of Cleveland / Case Medical Center
mi
from
Cleveland, OH
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
University Hospitals of Cleveland / Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
Texas Endosurgery Institute
mi
from
San Antonio, TX
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
Texas Endosurgery Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  2/16/2018
University of Utah Health Sciences Center and Huntsman Cancer Hospital
mi
from
Salt Lake City, UT
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 2/16/2018
University of Utah Health Sciences Center and Huntsman Cancer Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
Phase II Non-Randomized Pre-Surgical Study Evaluating Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) Who Are Eligible for Cytoreductive Nephrectomy
Status: Enrolling
Updated:  2/16/2018
Baylor College of Medicine
mi
from
Houston, TX
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
Phase II Non-Randomized Pre-Surgical Study Evaluating Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) Who Are Eligible for Cytoreductive Nephrectomy
Status: Enrolling
Updated: 2/16/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
Phase II Non-Randomized Pre-Surgical Study Evaluating Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) Who Are Eligible for Cytoreductive Nephrectomy
Status: Enrolling
Updated:  2/16/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
Phase II Non-Randomized Pre-Surgical Study Evaluating Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) Who Are Eligible for Cytoreductive Nephrectomy
Status: Enrolling
Updated: 2/16/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated:  2/16/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated: 2/16/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated:  2/16/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated: 2/16/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated:  2/16/2018
University of Washington Medical Center
mi
from
Seattle, WA
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated: 2/16/2018
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated:  2/16/2018
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression
Status: Enrolling
Updated: 2/16/2018
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer
Status: Enrolling
Updated:  2/16/2018
Mary Crowley Cancer Research Centers
mi
from
Dallas, TX
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer
Status: Enrolling
Updated: 2/16/2018
Mary Crowley Cancer Research Centers
mi
from
Dallas, TX
Click here to add this to my saved trials
Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection.
Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection Specimen in Its Entirety.
Status: Enrolling
Updated:  2/16/2018
University of Mississippi Medical Center
mi
from
Jackson, MS
Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection.
Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection Specimen in Its Entirety.
Status: Enrolling
Updated: 2/16/2018
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Atlanta, GA
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Honolulu, HI
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
East Orange, NJ
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
East Orange, NJ
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Albuquerque, NM
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
New York, NY
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Burbank, CA
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Burbank, CA
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Los Angeles, CA
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
San Francisco, CA
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Jacksonville, FL
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Miramar, FL
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Miramar, FL
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Chattanooga, TN
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Houston, TX
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Seattle, WA
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated:  2/17/2018
ImClone Investigational Site
mi
from
Buenos Aires,
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
Status: Enrolling
Updated: 2/17/2018
ImClone Investigational Site
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated:  2/19/2018
Mount Sinai Hospital
mi
from
New York, NY
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated: 2/19/2018
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated:  2/19/2018
University of Pennsylvania Hospital
mi
from
Philadelphia, PA
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated: 2/19/2018
University of Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated:  2/19/2018
Thomas Jefferson University
mi
from
Philadelphia, PA
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated: 2/19/2018
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated:  2/19/2018
Fox Chase Cancer Center
mi
from
Philadelphia, PA
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated: 2/19/2018
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated:  2/19/2018
Rhode Island Hospital
mi
from
Providence, RI
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated: 2/19/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated:  2/19/2018
Arizona Cancer Center
mi
from
Tucson, AZ
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated: 2/19/2018
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated:  2/19/2018
Georgetown University Medical Center
mi
from
Washington,
A Study of LY2801653 in Advanced Cancer
A Phase 1 Study of LY2801653 in Patients With Advanced Cancer
Status: Enrolling
Updated: 2/19/2018
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
The Effect Of Celecoxib On The Perioperative Inflammatory Response In Colon Cancer Patients - A Double-Blind Placebo-Controlled Trial
Status: Enrolling
Updated:  2/19/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
The Effect Of Celecoxib On The Perioperative Inflammatory Response In Colon Cancer Patients - A Double-Blind Placebo-Controlled Trial
Status: Enrolling
Updated: 2/19/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
A Phase II Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor and Other Non-Carcinomas
Status: Enrolling
Updated:  2/19/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
A Phase II Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor and Other Non-Carcinomas
Status: Enrolling
Updated: 2/19/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
University of California, San Diego
mi
from
San Diego, CA
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Boston Med Ctr
mi
from
Boston, MA
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials